Sonic Healthcare Ltd (ASX: SHL) shares have slipped further into the red in Thursday morning trade.

At the time of writing, the shares are down around another 1%, and they’re trading close to a decade low, at $18.57 each.

Today’s slide means the shares have now crashed 21% over the past two weeks, and they’re now 17% lower for the year to date.

What has happened to Sonic Healthcare shares?

After a strong sell-off earlier this year, ASX healthcare shares came back into favour recently. 

Ahead of the share price crash two weeks ago, Sonic Healthcare shares had rebounded around 28% from a 10-year low in Mid-May. And its shares didn’t move in isolation, either. Australian healthcare stocks have staged a major recovery over the past month, with the healthcare index rising around 18% over the past month.

But amid the sector recovery, Sonic Healthcare reported its results on the 20th of August, and it sent investors into a tailspin.

For FY26, the company reported a 13% increase in revenue and a 11% increase in underlying EBITDA to $1.933 billion. It also reported a 17% increase in underlying NPAT and strong organic revenue growth of 5%.

The result looks good on face value and was broadly in line with expectations, but there were concerns about the strength of Sonic Healthcare’s outlook and about margin pressure overseas.

At the time of its results announcement, the company said it expects continued organic growth across its major markets. This is expected to be underpinned by demand for personalised and preventative healthcare. 

The company also provided EBITDA guidance in the range of $1.95 billion to $2.03 billion (in constant currency). This excludes costs from its IT transformation program. 

It also flagged some earnings headwinds from regulatory changes in Switzerland and a slower ramp-up of profit from its large UK NHS contract.

Ahead of the result, analysts had pinpointed margin recovery as the key part of the investment case. So it looks like Sonic Healthcare’s outlook spooked investors, and many quickly sold up their shares and fled the stock.

So, what do the experts think?

Are the ASX healthcare shares a buy, sell, or hold now?

According to TradingView data, the majority of analysts are neutral about the outlook for Sonic Healthcare shares going forward.

Out of 18 analysts, 10 now have a hold rating. The remaining eight ratings are split between buy/strong buy and sell/strong sell.

The average $22.11 target price, however, does imply a potential 19% upside after the latest sell-off. Even the minimum $19.60 target price suggests the shares could climb another 5%, at the time of writing.

Bell Potter confirmed its buy rating on Sonic Healthcare shares shortly following the results announcement, but shaved its target price to $27.50. The broker said the result was in guidance. But added that the rebounding share price is mostly the result of a broad sector rebound.

The post Sonic Healthcare shares crash 21%: What on earth is going on? appeared first on The Motley Fool Australia.

More reading

• Why these ASX shares are worth watching closely today
• Could this 7%-yielding ASX healthcare share be a growth winner?
• Why this ASX healthcare share is a retiree’s dream for FY27
• Why I think these boring ASX shares could build serious wealth
• 37 ASX shares going ex-dividend next week

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Santos Ltd (ASX: STO) shares are edging lower today.

Shares in the S&P/ASX 200 Index (ASX: XJO) energy stock closed yesterday trading for $8.31. In morning trade on Thursday, shares are changing hands for $8.29 apiece, down 0.2%.

For some context, the ASX 200 is just about flat at this same time, while the S&P/ASX 200 Energy Index (ASX: XEJ) is down 1.2%.

Now, here’s what’s happening with Santos’ growth outlook.

Santos shares in focus amid major project progress

In news that could support Santos shares over the longer-term, the company announced a “significant milestone” at its Pikka oil project, located on Alaska’s North Slope.

Pikka is one of Santos’ two major growth projects that could help the ASX 200 oil and gas stock increase its production by up to 30% in the second half of the year (H2 2026) compared to H1.

And Pikka is fast progressing to full production, with Santos reporting the successful commencement of seawater injection at the Nanushuk Drillsite-B (NDB) within the project.

Continuous production at Pikka commenced in June.

The project is now delivering around 40,000 barrels of oil per day (gross). And Santos shares could catch further tailwinds, with management reporting the company plans to bring additional wells online over the coming weeks now that the water injection is also online.

The company said that water export from the seawater treatment plant began on 18 August via a 75-kilometre seawater pipeline that connects the Beaufort Sea to the Pikka project site.

With injection into the reservoir having started on 26 August, Santos said the water injection milestone testing has since been successfully completed. The current water injection was reported to be around 40,000 barrels per day.

Why is Santos injecting seawater?

The company explained:

Seawater injection provides pressure support to the reservoir, a key enabler of the production ramp-up targeting plateau production of approximately 80,000 barrels of oil per day (gross) at the end of the third quarter of 2026.

What did management say?

Commenting on the progress at Pikka that could provide long-term support for Santos shares, managing director and CEO Kevin Gallagher said:

Seawater injection is a critical step in unlocking Pikka’s production capacity. With pressure support now established and wells coming online progressively, we continue to target plateau production rates at the end of the third quarter of 2026.

Pikka is a world-class asset and seawater injection, together with continued efficient drilling and operations, keeps us firmly on track to deliver its full potential.

Santos share price snapshot

With today’s intraday moves factored in, shares in the ASX 200 energy stock are up 34.8% in 2026, well ahead of the 2.9% year to date gains posted by the benchmark index.

The post Buying Santos shares? Here’s why the company is celebrating this production milestone appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Thursday
• Buy, hold, sell: New Hope, BOQ, Santos shares
• Why is the ASX 200 having its worst day in 3 months?
• Santos versus Woodside shares: Which ASX energy stock outperformed in August?
• 5 things to watch on the ASX 200 on Wednesday

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Bond yields just hit their highest points since 2011, with Australia’s 10-year government bond yield reaching roughly 5.19%.

The US 10-year Treasury has climbed to 4.79%, its highest level since October 2023.

When the risk-free rate moves this far, the valuation of the market typically moves with it.

What the bond market is saying

June quarter GDP grew 0.4% and annual growth reached 2.1%, both faster than economists expected.

Meanwhile, trimmed mean inflation remains at 3.6%, comfortably above the Reserve Bank’s target band.

Traders now put a 60% probability on a rate rise at the 29 September meeting, up from 52% before the GDP release.

The three-year bond yield has pushed to 4.82%, which tells you the market expects higher rates to persist.

Why higher yields hurt some ASX shares more than others

The mechanism is simple arithmetic.

A company’s value is its future cash flows discounted back to today. By raising the discount rate, distant cash flows lose more value in today’s terms.

Businesses whose earnings are decades away, or which carry heavy debt, therefore suffer twice.

The result is a wholesale repricing of ASX shares.

Partly as a result of this, the S&P/ASX 200 (ASX:XJO) had its worst day in three months even as the growth data improved.

Transurban is the best example

Transurban Group (ASX: TCL) owns toll roads with concession periods running for decades.

The shares closed at $13.76 on Wednesday, down 1.43%, and now are close to a 52-week low of $13.25.

The distribution yield is 5.01%, which is almost exactly what the 10-year government bond pays.

That’s part of the problem. An investor can now earn a similar income from a government guarantee, without accepting traffic risk or $23 billion of debt.

The offset is that Transurban’s tolls escalate with inflation, so its cash flows grow while a bond coupon does not.

Higher inflation is typically good for the revenue line and typically bad for the discount rate applied to it.

Goodman Group is another exposed ASX share

Goodman Group (ASX: GMG) exhibits the same pressure as Transurban group

The company’s shares trade near $27.50 against a 52-week high of $34.78, on a price-to-earnings ratio of 20.87.

Despite this, the company’s results were strong. FY26 operating profit rose 15.7% to $2,675 million, with operating earnings per security up 10.1% to 129.9 cents.

Data centres now represent roughly $15.4 billion of work in progress, or 78% of the total.

Higher yields raise its cost of capital and lower the value of the assets it builds, which is a direct headwind.

The counterweight for the company is a 6.4 gigawatt power bank across 16 cities and FY27 guidance for 9% earnings growth.

Foolish takeaway

Higher yields are not a reason to abandon long-duration ASX shares.

But they could potentially offer more attractive entry points for long-term investors.

Transurban is closer to fair value than it has been for years, though its yield no longer looks that special beside a government bond.

Goodman still has the better growth story and is priced accordingly.

The mistake would be assuming the market has finished adjusting, because the bond market clearly has not.

The post Australian bond yields are back at 2011 levels. What does this mean for ASX shares? appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Liontown, Collins Foods, and Goodman shares
• Want to invest in AI shares? Here’s how to do it on the ASX
• How much passive income can I earn off a $630,000 superannuation balance
• The RBA could hike rates in September. Which ASX shares are most at risk?
• How much superannuation do I need to earn $90,000 per year in passive income?

Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group and Transurban Group. The Motley Fool Australia has positions in and has recommended Transurban Group. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.